Category: Joint ventures/collaborations
-
Smartwatch Monitor Boosts Parkinson’s Care
A university in the U.K. designed a home-based care plan for people with Parkinson’s disease that uses a smartwatch device to monitor their conditions.
-
FDA Expands Evidence Project to Replace Trials
The Food and Drug Administration is expanding a demonstration project with a Boston teaching hospital that tests the value of real world evidence to replace some clinical trials.
-
Biotechs Partner on Gene Silencing in $1.1B Deal
Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions.
-
Biotechs Join Forces for Off-the-Shelf Stem Cells
Two biotechnology enterprises working in genome editing and regenerative medicine are sharing their technologies to develop off-the-shelf cell therapies.
-
Immuno-, Chemotherapy Shown to Shrink Pancreatic Cancers
Early results from a clinical trial show a combination of immunotherapy and chemotherapy drugs shrunk tumors in most participants with pancreatic cancer.
-
Ancient DNA Studied for Mental Health Clues
A lab studying DNA from past civilizations and the genomics technology company Illumina are investigating remains of ancient peoples for insights into today’s neurological disorders.
-
Celgene Adopting A.I. Drug Discovery Technology
Drug maker Celgene is gaining access to an artificial intelligence platform developed by Exscientia Ltd, to find treatment candidates for cancer and autoimmune disorders.
-
NIH Funds Natural Hearing Restoration Technology
An international group of universities and companies is designing a next-generation device to restore more natural hearing to people suffering from hearing loss.
-
Gates Supporting Infectious Antibody Discovery
The Bill and Melinda Gates Foundation is enlisting a company that discovers therapeutic antibodies to help researchers develop new drugs and vaccines for serious infectious diseases.
-
Microsoft, Biotech Partner on Gene, Cell Therapies
A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies.